Cell & Gene Therapy Production
This week-long Cell and Gene Therapy Production stream focuses on the analysis, process development, scale-up and
manufacture of cell and gene-based products, with particular attention on CAR-T and TCR-based therapies. First stop is Cell
Therapy CMC, looking at potency assay development, raw materials, comparability, target product profiles and quality control,
followed by two days on cell therapy bioproduction – from scale-up to automation and closed systems; operations to logistics.
The final part of the week focuses on gene therapy and the challenges in vector design, development and manufacture for AAV
and lentiviruses, with supplementary sessions on analytics and CMC.
Cell Therapy CMC, Quality and Analytics
Cell Therapy Bioproduction, Operations and Logistics
Gene Therapy Bioproduction